Healius
Healius is a leading Australian diagnostics company providing essential healthcare services through a vast network of labs and diagnostic centers. With a focus on accessible and affordable healthcare, Healius leverages digital technologies to enhance service delivery and patient care.
Short position
Healius (ASX:HLS) has 2.54% of its shares on issue reported as short positions as of 5 Oct 2026, or about 18,426,064 shares. Over the past 30 days that figure has fallen 5.72 percentage points, and over 90 days it has fallen 7.48 percentage points. Its highest recorded short interest was 10.81% in June 2026. HLS is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Healius (HLS) short interest history
HLS Short Interest History
- 30-day change
- -5.72pp
- 90-day change
- -7.48pp
- 1-year change
- -1.03pp
- All-time high
- 10.81% (June 2026)
- All-time low
- 0.00% (April 2021)
Is HLS heavily shorted?
Not especially: 2.54% short interest is modest by ASX standards, ranking #134 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has HLS's short interest changed recently?
Over the past 30 days Healius's short interest has fallen 5.72 percentage points, and over 90 days it has fallen 7.48 percentage points. The current level is 2.54% of shares on issue.
What is the highest HLS's short interest has been?
Since 2010, Healius's short interest peaked at 10.81% in June 2026 and bottomed at 0.00% in April 2021.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2010. See our methodology.